[1]
|
Qazi, S., et al. (2015) Ending Preventable Child Deaths from Pneumonia and Diarrhoea by 2025. Development of the Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea. Archives of Disease in Childhood, 100, S23-S28. https://doi.org/10.1136/archdischild-2013-305429
|
[2]
|
Xu, J. and Gordon, J.I. (2003) Honor Thy Symbionts. Proceedings of the National Academy of Sciences of the United States of America, 100, 10452-10459. https://doi.org/10.1073/pnas.1734063100
|
[3]
|
Sekirov, I., Russell, S.L., Caetano, L., Antunes, M. and Brett Finlay, B. (2010) Gut Microbiota in Health and Disease. Physiological Reviews, 90, 859-904. https://doi.org/10.1152/physrev.00045.2009
|
[4]
|
Eckburg, P.B., et al. (2005) Diversity of the Human Intestinal Microbial Flora. Science, 308, 1635-1638.
https://doi.org/10.1126/science.1110591
|
[5]
|
Ling, Z., et al. (2013) Pyrosequencing Analysis of the Human Microbiota of Healthy Chinese Undergraduates. BMC Genomics, 14, Article No. 390. https://doi.org/10.1186/1471-2164-14-390
|
[6]
|
Ihekweazu, F.D. and Versalovic, J. (2018) Development of the Pediatric Gut Microbiome: Impact on Health and Disease. The American Journal of the Medical Sciences, 356, 413-423. https://doi.org/10.1016/j.amjms.2018.08.005
|
[7]
|
Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I. (2007) Mechanisms Underlying the Resistance to Diet-Induced Obesity in Germ-Free Mice. Proceedings of the National Academy of Sciences of the United States of America, 104, 979-984. https://doi.org/10.1073/pnas.0605374104
|
[8]
|
Herremans, K.M., Riner, A.N., Cameron, M.E. and Trevino, J.G. (2019) The Microbiota and Cancer Cachexia. International Journal of Molecular Sciences, 20, 6267. https://doi.org/10.3390/ijms20246267
|
[9]
|
张琪琛, 谢晓丽. 小儿慢性迁延性腹泻102例病因分析与治疗对策探讨[J]. 儿科药学杂志, 2014, 20(8): 18-20.
|
[10]
|
王珺, 刘泉波, 许红梅. 儿童迁延性慢性腹泻的病因分析[J]. 中国社区医师, 2011, 27(30): 9.
|
[11]
|
Fernandes, M.R., et al. (2017) Alterations of Intestinal Microbiome by Antibiotic Therapy in Hospitalized Children. Microbial Drug Resistance, 23, 56-62. https://doi.org/10.1089/mdr.2015.0320
|
[12]
|
Long, C.X., et al. (2017) Diversity of Bacterial Lactase Genes in Intestinal Contents of Mice with Antibiotics-Induced Diarrhea. World Journal of Gastroenterology, 23, 7584-7593. https://doi.org/10.3748/wjg.v23.i42.7584
|
[13]
|
龚舒, 等. 幽门螺杆菌相关胃炎患儿肠道菌群分析[J]. 现代医药卫生, 2020, 36(6): 885-887.
|
[14]
|
钱明, 袁君君, 李文辉. 粪便涂片在诊断腹泻患儿肠道菌群失衡中的临床意义[J]. 中国医学创新, 2011, 8(19): 80-81.
|
[15]
|
张秀荣. 肠道菌群粪便涂片检查图谱[M]. 北京: 人民军医出版社, 2000.
|
[16]
|
孙雪荣. 探析粪便涂片在诊断腹泻患儿肠道菌群失调中的临床意义[J]. 临床检验杂志(电子版), 2018, 7(2): 285.
|
[17]
|
浦越, 等. 粪便涂片在诊断腹泻患儿肠道菌群失调中的临床意义[J]. 中国临床研究, 2017, 30(1): 102-104.
|
[18]
|
Wen, H., et al. (2018) Comparative Analysis of Gut Microbial Communities in Children under 5 Years Old with Diarrhea. Journal of Microbiology and Biotechnology, 28, 652-662. https://doi.org/10.4014/jmb.1711.11065
|
[19]
|
Lange, K., Buerger, M., Stallmach, A. and Bruns, T. (2016) Effects of Antibiotics on Gut Microbiota. Digestive Diseases, 34, 260-268. https://doi.org/10.1159/000443360
|
[20]
|
Jernberg, C., Löfmark, S., Edlund, C. and Jansson, J.K. (2007) Long-Term Ecological Impacts of Antibiotic Administration on the Human Intestinal Microbiota. The ISME Journal, 1, 56-66. https://doi.org/10.1038/ismej.2007.3
|
[21]
|
Migriauli, I., et al. (2018) Factors Affecting Development of Clostridium difficile Infection in Hospitalized Pediatric Patients in the Country Georgia. BMC Research Notes, 11, Article No. 409. https://doi.org/10.1186/s13104-018-3517-0
|
[22]
|
Predrag, S., et al. (2018) Community-Acquired Clostridium difficile Infection in Serbian Pediatric Population. The European Journal of Clinical Microbiology & Infectious Diseases, 37, 1061-1069.
https://doi.org/10.1007/s10096-018-3218-6
|
[23]
|
Adams, D.J., et al. (2017) Risk Factors for Community-Associated Clostridium difficile Infection in Children. The Journal of Pediatrics, 186, 105-109. https://doi.org/10.1016/j.jpeds.2017.03.032
|
[24]
|
Khanna, S., et al. (2013) The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study. Clinical Infectious Diseases, 56, 1401-1406. https://doi.org/10.1093/cid/cit075
|
[25]
|
McDonald, L.C., et al. (2018) Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 66, e1-e48. https://doi.org/10.1093/cid/cix1085
|
[26]
|
Louie, T.J., et al. (2011) Fidaxomicin versus Vancomycin for Clostridium difficile Infection. The New England Journal of Medicine, 364, 422-431. https://doi.org/10.1056/NEJMoa0910812
|
[27]
|
Cornely, O.A., et al. (2012) Fidaxomicin versus Vancomycin for Infection with Clostridium difficile in Europe, Canada, and the USA: A Double-Blind, Non-Inferiority, Randomised Controlled Trial. The Lancet Infectious Diseases, 12, 281-289. https://doi.org/10.1016/S1473-3099(11)70374-7
|
[28]
|
Wolf, J., et al. (2020) Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-Blind Clinical Trial (SUNSHINE). Clinical Infectious Diseases, 71, 2581-2588. https://doi.org/10.1093/cid/ciz1149
|
[29]
|
van Nood, E., et al. (2013) Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. The New England Journal of Medicine, 368, 407-415. https://doi.org/10.1056/NEJMoa1205037
|
[30]
|
Fareed, S., et al. (2018) Applying Fecal Microbiota Transplantation (FMT) to Treat Recurrent Clostridium difficile Infections (rCDI) in Children. PeerJ, 6, e4663. https://doi.org/10.7717/peerj.4663
|
[31]
|
Aldrich, A.M., et al. (2019) Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital. The Pediatric Infectious Disease Journal, 38, 32-36.
https://doi.org/10.1097/INF.0000000000002053
|
[32]
|
Li, X., et al. (2018) Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children with Recurrent Clostridium difficile Infection. Frontiers in Microbiology, 9, Article No. 2622.
https://doi.org/10.3389/fmicb.2018.02622
|
[33]
|
Durovic, A. and Tschudin-Sutter, S. (2021) Cutting Edges in Clostridioides difficile Infections. Swiss Medical Weekly, 151, w30033. https://doi.org/10.4414/SMW.2021.w30033
|
[34]
|
Dieterle, M.G. and Young, V.B. (2017) Reducing Recurrence of C. difficile Infection. Cell, 169, 375.
https://doi.org/10.1016/j.cell.2017.03.039
|
[35]
|
Xiao, Z., et al. (2021) A Potential Probiotic for Diarrhea: Clostridium tyrobutyricum Protects Against LPS-Induced Epithelial Dysfunction via IL-22 Produced by Th17 Cells in the Ileum. Frontiers in Immunology, 12, Article ID: 758227. https://doi.org/10.3389/fimmu.2021.758227
|
[36]
|
Zhu, H.M., et al. (2019) Effect of Water Extract from Berberis heteropoda Schrenk Roots on Diarrhea-Predominant Irritable Bowel Syndrome by Adjusting Intestinal Flora. Journal of Ethnopharmacology, 237, 182-191.
https://doi.org/10.1016/j.jep.2019.03.045
|
[37]
|
Qi, Y.L., et al. (2019) Effects of Ginseng Neutral Polysaccharide on Gut Microbiota in Antibiotic-Associated Diarrhea Mice. China Journal of Chinese Materia Medica, 44, 811-818.
|
[38]
|
Xu, B., et al. (2020) Cortex Phellodendri Extract’s Anti-Diarrhea Effect in Mice Related to Its Modification of Gut Microbiota. Biomedicine & Pharmacotherapy, 123, Article ID: 109720. https://doi.org/10.1016/j.biopha.2019.109720
|